Literature DB >> 2236588

Decreased alcohol consumption by verapamil in alcohol preferring rats.

A H Rezvani1, D S Janowsky.   

Abstract

1. Calcium channel blockers have been proposed, in addition to inhibiting the influx of Ca++ into the cells, to possess a wide variety of pharmacological effects, including interference with certain neurotransmitters involved in mood, mental disorders and alcohol craving. Further, it has been documented that certain neurotransmitters are involved in alcohol craving both in animals and humans. 2. To investigate the effects of Ca(++)-channel antagonist on alcohol preference, verapamil in three doses (5, 10 and 15 mg/kg) was injected (S.C.) twice daily over a period of one day in alcohol-preferring (P) and alcohol non-preferring (NP) rats at 9:00 a.m. and 4:00 p.m. 3. Water, alcohol and food intake were monitored. 4. Our results show that verapamil in doses of 10 and 15 mg/kg significantly (p less than 0.02 and 0.01, respectively) reduced the intake of ethanol and increased the intake of water by P rats. However, injection of an equal volume of saline did not change the pattern of alcohol intake. 5. These results suggest that a (++(+)-channel blocker such as verapamil, could, at least partially, attenuate alcohol preference in alcohol preferring rats. It is possible that verapamil exerts an inhibitory effect on alcohol preference by interfering with Ca++ channels, blocking serotonin uptake or through another mechanism(s).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2236588     DOI: 10.1016/0278-5846(90)90013-7

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  7 in total

Review 1.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation.

Authors:  Giovanni Addolorato; Lorenzo Leggio; F Woodward Hopf; Marco Diana; Antonello Bonci
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

Review 3.  From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.

Authors:  Zeeba D Kabir; Arlene Martínez-Rivera; Anjali M Rajadhyaksha
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

4.  Differential Roles for L-Type Calcium Channel Subtypes in Alcohol Dependence.

Authors:  Stefanie Uhrig; David Vandael; Andrea Marcantoni; Nina Dedic; Ainhoa Bilbao; Miriam A Vogt; Natalie Hirth; Laura Broccoli; Rick E Bernardi; Kai Schönig; Peter Gass; Dusan Bartsch; Rainer Spanagel; Jan M Deussing; Wolfgang H Sommer; Emilio Carbone; Anita C Hansson
Journal:  Neuropsychopharmacology       Date:  2016-12-01       Impact factor: 7.853

5.  Suppression of alcohol and saccharin preference in rats by a novel Ca2+ channel inhibitor, Goe 5438.

Authors:  O Pucilowski; A H Rezvani; D S Janowsky
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 6.  Alcoholism and alternative splicing of candidate genes.

Authors:  Toshikazu Sasabe; Shoichi Ishiura
Journal:  Int J Environ Res Public Health       Date:  2010-03-30       Impact factor: 3.390

Review 7.  Neuroscience of alcoholism: molecular and cellular mechanisms.

Authors:  Sachin Moonat; Bela G Starkman; Amul Sakharkar; Subhash C Pandey
Journal:  Cell Mol Life Sci       Date:  2009-09-10       Impact factor: 9.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.